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Brief Definit ive Report
The success of the adaptive immune system in 
maintaining health is dependent on recognition 
of specific pathogens or vaccine epitopes by 
cell-unique antigen receptors of B and T lym-
phocytes. An inevitable drawback to a system 
that depends on extreme receptor diversity is 
the potential to break self-tolerance by binding 
autoantigens. Transitional B cells are bone mar-
row–derived immature B cells that continu-
ously emerge into the blood-borne B cell pool 
throughout life. A relatively high proportion of 
transitional B cells express polyspecific immu-
noglobulin that may give rise to the autoim-
mune repertoire (Meffre and Wardemann, 2008; 
Mietzner et al., 2008). Transitional B cells can be 
divided into subsets based on stage of matura-
tion; transitional 1 (T1) cells mature to T2 and 
possibly T3 before reaching maturity (Bemark 
et al., 2012). In mice, transitional B cells mature 
in bone marrow and spleen through a process 
that involves a bifurcation in B cell fate to either 
circulating follicular B cells or splenic resident 
marginal zone B cells. Both are mature naive 
populations; the former generate conventional 
adaptive T cell–dependent B cell responses, 
whereas the latter are responsible for more in-
nate type responses to T-independent antigens 
such as pneumococcal polysaccharide. This is 
unlikely to occur equivalently in humans where 
splenic zonal microanatomy is different (Mebius 
and Kraal, 2005; Vossenkämper and Spencer, 
2011) and where there are fundamental differ-
ences in B cell subset biology. For example, mice 
have a self-renewing peritoneal B1 B cell pop-
ulation that humans do not have equivalently. 
In addition, the enigmatic human marginal zone 
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We have tracked the fate of immature human B cells at a critical stage in their develop-
ment when the mature B cell repertoire is shaped. We show that a major subset of bone 
marrow emigrant immature human B cells, the transitional 2 (T2) B cells, homes to gut-
associated lymphoid tissue (GALT) and that most T2 B cells isolated from human GALT are 
activated. Activation in GALT is a previously unknown potential fate for immature human  
B cells. The process of maturation from immature transitional B cell through to mature  
naive B cell includes the removal of autoreactive cells from the developing repertoire, a 
process which is known to fail in systemic lupus erythematosus (SLE). We observe that 
immature B cells in SLE are poorly equipped to access the gut and that gut immune compart-
ments are depleted in SLE. Thus, activation of immature B cells in GALT may function as a 
checkpoint that protects against autoimmunity. In healthy individuals, this pathway may be 
involved in generating the vast population of IgA plasma cells and also the enigmatic 
marginal zone B cell subset that is poorly understood in humans.
© 2013 Vossenkämper et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Figure . A subpopulation of transitional B cells is recruited to the GALT. (A and B) Healthy peripheral blood and Peyer’s patch B cells were ana-
lyzed by flow cytometry for the expression of CD19, CD20, CD27, CD24, CD38, CD10, and IgD. FACS plots display the percentages of T1, T2, and naive B cells, 
and histograms display CD10 and IgD expression for each subset, healthy control blood (A) and Peyer’s patches (B). Plots show one of four experiments 
with similar results. (C) Confocal microscopy of human Peyer’s patch. CD10+ (red), IgD+ (green) transitional B cells are highlighted by arrows at the periphery 
of the germinal center. GC, germinal center; MZ, marginal zone. One of three experiments with similar results is shown. (D) Immunohistochemistry of 
GALT identifies CD10+ (pink) and IgD+ (brown) transitional B cells in the periphery of the germinal center. One of three experiments with similar results  
is shown. (E) Immunohistochemistry of GALT showing CD10+ cells (brown) scattered in the mantle zone of GALT. One of three experiments with similar 
results is shown. (F and G) T1, T2, and naive B cells were identified by flow cytometry (as in A and B) in F. Perfusates from normal liver grafts and matched 
donor blood (G) are shown. One of three experiments with similar results is shown. (H) Ratios of the %T2 to %T1 subpopulations in normal blood, 
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B cell subset, while retaining the functional association with 
T-independent antigen, paradoxically has somatically hyper-
mutated immunoglobulin heavy chain variable regions genes 
(IGHVs), suggesting a history of antigen exposure and germi-
nal center transit.
Although neither the anatomical nor mechanistic bases 
for human B cell maturation after bone marrow exit are un-
derstood in humans, a checkpoint is known to exist that de-
pletes cells with autoreactivity and polyspecificity from the 
bone marrow–emergent transitional B cell repertoire before 
differentiation to mature naive B cells. Failure of this check-
point is apparent in systemic lupus erythematosus (SLE) 
where immature B cells are relatively abundant in blood and 
the polyspecific and autoreactive cells are not depleted from 
the mature naive repertoire (Yurasov et al., 2005; Meffre and 
Wardemann, 2008).
In mice, the fate of immature B cells is determined in 
spleen, but there is no evidence that this occurs in humans. 
However, in humans there is circumstantial evidence point-
ing to an association between gut-associated lymphoid tissue 
(GALT) and the spleen: first, the human splenic marginal 
zone B cell population expands in response to mucosal bacte-
rial infection (Harris et al., 1996); second, low-grade malig-
nancies of mucosal marginal zone B cells (mucosa-associated 
lymphoid tissue lymphomas), which parody the behavior of 
their normal healthy counterparts, migrate to the splenic 
marginal zone (Du et al., 1997); and third, marginal zone 
B cells in humans have evidence of previous antigen encoun-
ter (Weill et al., 2009). We therefore considered the possibil-
ity that human GALT could be involved in determining the 
fate of immature B cells and may influence repertoire devel-
opment. The human gut is the largest immune organ in the 
body, with more effector cells, including plasma cells, than 
all other sites of immune expression in the body combined 
(Pabst et al., 2008). These plasma cells are generated in GALT 
that is maintained in a chronically activated state by the lumi-
nal microbiota.
RESULTS AND DISCUSSION
The T2 subset of human transitional B cells  
selectively localizes in GALT
We initially asked if GALT might recruit lymphocytes from 
the immature B cell pool. Subsets of B cells were analyzed 
in suspensions of mononuclear cells isolated from human 
Peyer’s patches that were selectively sampled at endoscopy. 
The T2 subset of transitional B cells was consistently enriched 
in isolated Peyer’s patch cell suspensions compared with the 
T1 subset (Fig. 1, A and B; and Fig. S1). Consistent with 
this, cells with transitional B cell phenotype were identified 
on the periphery of GALT germinal centers (Fig. 1, C and D), 
and as scattered CD10+ cells around the periphery of the 
mantle zone where it merges with the mucosal marginal zone 
(Fig. 1, D and E).
Recruitment of T2 cells into GALT would logically re-
move them from the blood circulation so that they would be 
selectively depleted from the venous blood that drains to the 
liver via the hepatic portal vein; most of the blood in the he-
patic portal vein has previously passed through the gut. To 
confirm the selective recruitment of T2 cells to the gut, we 
analyzed the mononuclear cells obtained by vascular perfu-
sion of normal liver before liver transplant. The T2 subset of 
transitional B cells was significantly reduced in the mono-
nuclear cell population obtained by perfusion compared with 
paired donor blood samples (Fig. 1, F and G). The ratio of T2 
to T1 transitional cells was higher in Peyer’s patch cells and 
lower in liver perfusates compared with control and paired 
blood samples (Fig. 1 H), further confirming the selective re-
cruitment of T2 transitional cells to the gut.
The interaction between integrin 47 on lymphocytes 
and the endothelial ligand MAdCAM-1 that is expressed by 
endothelium in GALT (Brandtzaeg et al., 1999; Fig. 1 I) medi-
ates the localization of lymphoid cells in the gut. We therefore 
asked if the selective recruitment of T2 transitional B cells in 
the gut might be associated with a higher expression of 47. 
A greater percentage of blood transitional B cells expressed 
high levels of 47 integrin (7 expression considered repre-
sentative for 47; Rott et al., 1996) than naive B cells, with 
the highest proportion of expression being within the T2 subset 
(Fig. 1, J and K). Residual T2 cells observed in liver perfusates 
were the T2 cells with lowest expression of 47 integrin, 
consistent with prior sequestration of T2 cells with higher 
47 integrin expression in GALT (Fig. 1, J and K).
The majority of T2 B cells in GALT are activated
Having observed that T2 cells are selectively recruited into 
GALT, we considered what the consequences of this might 
be. GALT is rich in exogenously derived bacterial antigens 
from the luminal microbiota. We therefore asked whether 
transitional B cells might be activated in the GALT micro-
environment. Freshly isolated GALT transitional B cells were 
observed to have phosphorylated Bruton’s tyrosine kinase 
(BTK), Erk, and Syk (Fig. 2 A), indicative of recent activation 
in vivo (Aoki et al., 1994). This frequency was significantly 
higher than that observed in other B cell subsets from GALT 
matched liver donor blood, liver graft perfusates, and normal Peyer’s patches. Error bars show mean ± SEM. Statistical test: one-way ANOVA. n = up to 
15. ***, P < 0.0001; **, P < 0.003. (I) Immunohistochemistry showing MAdCAM (brown) and CD20 (pink). MAdCAM is seen on Peyer’s patch vessels (marked 
by arrowheads). One of two experiments with similar results. (J and K) Healthy control blood, liver perfusates, and matched donor blood samples were 
analyzed by flow cytometry for the expression of CD19, CD20, CD27, CD24, CD38, and 7 integrin. One of three experiments with similar results is shown. 
(J) FACs plots display 7 expression on T1, T2, and naive B cells (K) Summary data showing percentages of naive, T1, and T2 B cells in normal peripheral 
blood and liver graft perfusates that express 7 integrin. n = 7–16. Error bars show mean ± SEM. Statistical test: one-way ANOVA. ***, P < 0.0001;  
**, P < 0.0043.
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Figure 2. GALT transitional B cells are activated in vivo and in vitro in response to intestinal bacteria. (A) Mononuclear cells were isolated 
from Peyer’s patches and analyzed directly ex vivo by flow cytometry for their expression of CD19, CD10, IgD, and phospho-BTK, phospho-Syk, and  
phospho-ERK. Representative histograms displaying the degree of BTK, Syk, and ERK phosphorylation for CD19+CD10+IgD+ transitional (TS) and 
CD19+CD10+IgD germinal center (GC) B cells. Shown is one of three experiments with similar results. (B) PBMCs were stimulated polyclonally for 30 min 
with CpG, anti-IgM, and heat-inactivated intestinal bacteria as a positive control for B cell kinase phosphorylation, or left unstimulated. After stimu-
lation, cells were analyzed by flow cytometry for the expression of CD19, CD20, CD27, CD24, CD38, and phospho-BTK, phospho-Syk, and phospho-ERK. 
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or blood (Barone et al., 2011; Fig. 2, A and B). The relatively 
low frequency of kinase phosphorylation in GC B cells 
is consistent with previous studies (Barone et al., 2011; Khalil 
et al., 2012).
The different percentages of cells detected by the different 
anti-kinase antibodies (Fig. 2 A) probably reflects the different 
signaling pathways that the kinases may contribute to and the 
different potential routes that might be involved in the acti-
vation of individual B cells, including activation through the 
BCR and TLRs. Higher frequencies of transitional and naive 
B cells with pBTK, pErk, and pSyk could be induced by poly-
clonal activation of peripheral blood mononuclear cell (PBMC) 
used as a positive control (Fig. 2 B).
To mimic the phenomena observed in vivo, T1, T2, and 
naive B cells were FACS sorted from blood (gating strategy 
shown in Fig. S2 A) and coincubated with washed heat- 
inactivated isolates of bacteria from the intestinal lumen. Phos-
phorylation of BTK in blood transitional B cells could be 
initiated in vitro by coincubation with washed heat-inactivated 
isolates of bacteria from the intestinal lumen (Fig. 2 C). There-
fore antigens derived from the intestinal microbiome could 
potentially induce the activated state of transitional B cells 
in vivo. The relatively high activity of the T1 cells might be 
related to the expression of TLR9 and comparatively high 
frequency of cells expressing polyspecific receptors (Yurasov 
et al., 2005; Aranburu et al., 2010). Supernatant of T1, T2, and 
naive B cells isolated from Peyer’s patches or blood that had 
been incubated with washed heat-inactivated isolates of bac-
teria from the intestinal lumen gave positive results for pres-
ence of autoantibody, according to cut off controls provided 
with the assay for clinical diagnoses (Fig. 2, D and E). Such 
studies of cells isolated from human GALT involved pooling 
of samples and, therefore, it was not possible to assess variabil-
ity in these experiments. The production of autoantibodies 
may relate to a previously described ability of some antibodies 
produced by plasma cells in the gut, which are known to be 
derived from GALT, to cross react between autoantigens and 
gut bacterial antigens (Benckert et al., 2011).
Blood transitional B cells have immunoglobulin heavy 
chain variable region gene (IGHV) sequences that are unmu-
tated from germline (Aranburu et al., 2010; Wu et al., 2010), 
consistent with their naive status. However, transitional B cells 
can acquire somatic mutations in vitro on activation (Aranburu 
et al., 2010). Because GALT transitional B cells are activated 
in vivo (Fig. 2 A), we asked whether they might have somatic 
mutations in their IGV genes. Transitional and germinal cen-
ter B cells were isolated from GALT by a method that yielded 
populations with >99% purity (Fig. S2 B). Although the 
majority of transitional B cells had unmutated IGHV genes, 
30% had three or more mutations in IGHV. The frequency of 
mutation was significantly lower than that observed in the 
GC (Fig. 2 F). This observation was consistent between seven 
individual donors (Fig. 2 G). We identified examples of clonal 
expansion in the GC B cells by the observation of the same 
IGHV rearrangements in different PCR reactions (Fig. 2, 
H and I). However, these clones were not observed in the 
transitional B cell samples from the same individual. No 
clones were observed in the transitional B cell samples. The 
different population profiles of germinal center cells and tran-
sitional B cells in terms of both population sort purity and 
features of the immunoglobulin gene sequences confirmed 
that we analyzed these two CD10-expressing populations in-
dependently and that the mutations identified in the transi-
tional B cells were highly unlikely to be a result of germinal 
center cell contamination.
The intestinal immune system is depleted in SLE
Because T2 transitional B cells are selectively recruited to 
GALT where they acquire an activated state, we hypothesized 
that this could have a major impact on B cell repertoire devel-
opment, as activation of transitional B cells by antigens in 
GALT would by definition remove them from the naive cir-
culating pool. This could constitute a novel specificity check-
point, failure of which may result in pathology, and might 
constitute a checkpoint that is not functional in an auto-
immune disease such as SLE, which is reported to be B cell 
driven. We tested our hypothesis by studying SLE (Table S1; 
Yurasov et al., 2005, 2006; Meffre and Wardemann, 2008; 
Mietzner et al., 2008). We observed that lymphocytes in SLE, 
including transitional B cells, had significantly lower expres-
sion of 47 compared with healthy controls, implying a re-
duced potential to localize in the gut in SLE and reduced 
potential to access GALT (Fig. 3 A). Rheumatoid arthritis 
(RA) was studied as a disease control because it is also a 
Histograms display the degree of BTK, Syk, and ERK phosphorylation for T1, T2, and naive B cells. Histograms show one of three experiments. (C) FACS-
sorted T1 cells (CD19+ CD20+ CD27 CD24++ CD38++), T2 cells (CD19+ CD20+ CD27 CD24+ CD38+), and naive mature B cells (CD19+ CD20+ CD27 CD24 
CD38) isolated from normal blood were incubated with combinations of heat-inactivated intestinal bacteria, CpG, and anti-IgM for 30 min, followed by 
intracellular staining for phospho-BTK. Mean values + SD from three independent experiments are shows. (D and E) Autoantibody secretion by in vitro 
stimulated peripheral blood and Peyer’s patch B cells. T1, T2, and naive mature B cells were FACS sorted (sort strategy as in Fig. S2 A) from normal blood 
and Peyer’s patches (one experiment with pooled cells from three donors) and were incubated with heat-inactivated intestinal bacteria for 8 d. Super-
natants were screened for secreted autoantibodies by Hep-2 ELISA. Graphs show Hep-2 binding IgG (D) and IgA (E) autoantibodies. Data are standardized  
so that reactivity of supernatant from blood naive cells is 1 for each isotype. (F and G) IGHV genes were amplified by PCR from FACS-sorted TS and GC  
B cells isolated from Peyer’s patches of seven different donors (gated and sorted as shown in Fig. S2 B) from two sorts. (F) Pooled data of the number of 
mutations in GC or TS IGHV genes. Mann-Whitney test, P = 0.0001. (G) Number of mutations in GC or TS IGHV genes segregated by donor. Horizontal 
bars show the mean number of mutations. (H and I) An example of mutations in clonally related germinal center B cells. (H) Examples of IGHV sequencing 
of germinal center B cells showing four clonally related sequences deriving from a common ancestor. (I) Graphical explanation of the relation of the 
clones in H to a common ancestor and their germline precursor.
 
 o
n
 August 13, 2013
jem.rupress.org
D
ow
nloaded from
 
Published August 12, 2013
 of 0 Immature B cells enter GALT | Vossenkämper et al.
Figure . Expression of 7 integrin on TS B cells is impaired in SLE. (A) PBMCs isolated from healthy donors and patients with SLE were analyzed 
by flow cytometry for the expression of CD19, CD20, CD27, CD24, CD38, and 7. Graph displays the percentages of 7+ healthy or SLE T1, T2, and mature 
B cells. ***, P < 0.001 one-way ANOVA + Bonferroni’s multiple comparison test. (B) PBMCs isolated from SLE and RA patients were analyzed by flow  
cytometry as in A. Graph shows percentages of 7+ SLE and RA B cell subsets segregated into patients treated with or without hydroxychloroquine.  
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chronic inflammatory autoimmune disease treated with im-
munosuppressive drugs. Expression of 47 by B cells in 
RA was the same as in healthy controls (Fig. 3 A). To exclude 
the possibility that lower expression of 47 in SLE was a 
consequence of treatment with hydroxychloroquine (HCQ), 
which is known to interfere with TLR9 signaling, we divided 
patients according to whether they took HCQ medication or 
not. Expression of 47 directly ex vivo was not associated 
with HCQ and was not associated with any other immuno-
suppressive treatment (Fig. 3 B). Furthermore, we observed 
a failure to up-regulate 7 expression on SLE blood B cells 
compared with normal blood B cells after in vitro stimulation 
with CpG and retinoic acid, and this was irrespective of HCQ 
treatment (Fig. 3 C).
Having observed reduced expression of 47 by circu-
lating B cell subsets in patients with SLE, we reasoned that if 
this is relevant to immune physiology by reducing immune 
access to the gut, then GALT should be depleted in SLE. We 
analyzed random histologically normal biopsies, including 
25 from healthy controls and 38 from patients with SLE. 
Aggregates of lymphoid cells that did not show features of 
GALT were observed in biopsies from healthy and SLE donors 
(Fig. 3 D). However, whereas multiple examples of GALT 
were observed in healthy donors, no examples of GALT were 
observed in the sample of SLE biopsies (Fig. 3, D and E). 
A significantly lower density of IgA plasma cells was observed 
in the lamina propria in SLE compared with controls (Fig. 3 F). 
Reduced expression of 47 was also detected on blood 
T lymphocytes from SLE patients (Fig. 3 G). The intraepithe-
lial T cell compartment was significantly depleted in the large 
and small intestines of patients with SLE (Fig. 3, H and I) 
irrespective of treatment. CD4 and CD8 cells were present 
in the lamina propria, but CD8 cells did not tend to localize 
in the epithelium in SLE as they do in health (Fig. 3 I).
The receptors for retinoic acid and estrogen are nuclear 
receptors, the signaling pathways of which have been ob-
served to interact (Hua et al., 2009). RAR binding is highly 
coincident and overlaps with estrogen receptor  binding. 
Further analysis showed that these two nuclear receptor– 
signaling systems could antagonistically regulate their target 
genes (Hua et al., 2009). Estrogens can also alter B cell behavior 
(Grimaldi et al., 2002; Hill et al., 2011). We added -estradiol 
to lymphocytes at high and low physiological plasma concen-
trations. A consistent dose-dependent interference with the 
retinoic acid induction of 47 by -estradiol was observed 
in healthy blood B cells (Fig. 3, J and K). We saw no evidence 
of differences in expression of retinoic acid receptor , or activ-
ity of retinaldehyde dehydrogenase between SLE and health 
(Fig. 3, L and M; and Fig. S3), and no evidence of elevated 
estrogens in the small sample of the SLE patients analyzed. 
The mechanism of dysregulation of 47 integrin in SLE is 
not known but may be related to signals downstream of estro-
gen binding (Grimaldi et al., 2005).
Transitional B cells activated in GALT could be precursors  
of plasma cells or marginal zone B cells
The fate of the T2 cells activated in GALT remains unknown, 
but we propose that they could be precursors of either mar-
ginal zone B cells, intestinal plasma cells, or they could die. 
The origin of human splenic marginal zone B cells has been 
a tantalizing unknown for many years (Weill et al., 2009). In 
mice, transitional B cells mature into either naive B cells or 
marginal zone B cells in the spleen. This does not happen in 
humans where the splenic anatomy is different and the mar-
ginal zone B cell population, in contrast to murine marginal 
zone B cells, has somatic mutation in IGV. Data presented 
here suggests that human splenic marginal zone B cells could 
arise from transitional B cells activated in GALT, two zones 
Statistics: Kruskal-wallis + Dunn’s multiple comparison test. (C) Peripheral blood B cells from healthy individuals and SLE patients were cultured for 7 d with 
indicated treatments (10 µg/ml anti-IgM, 1 µM CpG, 100 nM RA, and 1 µM Ro41). Graph shows 7 expression analyzed by flow cytometry. Means + SEM 
of three independent experiments are shown. P = 0.04, Mann-Whitney-test. (D) Intestinal biopsies were taken from eight healthy and eight SLE patients 
(up to eight biopsies per patient). The biopsies were stained by immunohistochemistry for CD3, IgD, or CD20 and were scored according to whether sec-
tions contained no lymphoid tissue (diffuse lymphoid infiltrates), diffuse lymphoid aggregates only (aggregates), or structured lymphoid tissue (GALT). 
GALT in biopsies from healthy individuals versus SLE P < 0.004, 2. (E) Representative histological pictures of a healthy biopsy displaying GALT and an SLE 
biopsy showing a diffuse lymphoid aggregate lacking GALT features. CD20, IgD, and CD3 are stained brown. Bar, 75 µm. (F) Biopsies in D were stained for 
the presence of IgA+ plasma cells identified by their morphology and cytoplasmic IgA. Graphs show mean plasma cell density. Each data point is a mean 
of several biopsies from each donor, P = 0.03, Mann-Whitney-Test. (G) PBMCs isolated from SLE patients and healthy controls were analyzed by flow 
cytometry for CD3 and 7 expression. Graph displays the mean percentage of CD3+ T cells expressing 7. P = 0.0078, Mann-Whitney-Test. (H) Sections of 
intestinal biopsies isolated from the Ileum and colon of healthy controls and patient with SLE were stained with CD3. Graph shows mean percentages of 
intraepithelial lymphocytes (IEL) as percentage of total epithelial cells and IEL. *, P = 0.03; **, P = 0.004, Mann-Whitney Test. (I) Representative examples 
of immunohistochemistry of intestinal biopsies from healthy controls or SLE patients, stained for CD3 (brown) or CD4 (brown) and CD8 (pink). Bar, 20 µm. 
(J) Percent of 7-expressing CD19+ blood B cells after 7-d culture with indicated treatments (-IgM 10 µg/ml; CpG 1 µM; RA 100 nM; E50/100/200 =  
-estradiol 50/100/200 pg/ml). Analysis was performed by flow cytometry. Shown are means + SEM of three independent experiments. *, P = 0.02, two-
tailed Student’s t test. (K) Flow cytometry analysis of 7-expressing CD19+ blood B cells after 7-d culture with indicated treatments (IgM 10 µg/ml; CpG 
1 µM; RA 100 nM; E50/100/200 = -estradiol 50/100/200 pg/ml). The figure shows representative FACS plots of one of three experiments with similar 
results. (L) Transitional B cells were FACS sorted from the peripheral blood of healthy controls and patients with SLE based on their expression of CD19, 
IgD, and CD38. Sorted CD19+IgD+CD38+ transitional B cells were analyzed for RARalpha transcripts by RT-PCR, n = 6. The graph shows mean relative copy 
number for each group. No difference was observed. (M) Flow cytometric analysis of ALDH enzyme activity in blood myeloid dendritic cells (lineage HLA-
DR+ CD11c+) from lupus and control blood samples using the Aldefluor reagent system. Mean percentages of myeloid DCs that were ALDH+ are shown.  
n = 5. P = 0.3, two-tailed Mann-Whitney-test.
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Perfusate and donor PBMC collection. Liver perfusates were collected 
from human liver grafts. During procurement of the donor liver, the aorta 
was clamped and the liver was perfused through the portal vein with 2 liters 
of University of Wisconsin (UW) solution to remove residual blood from the 
vasculature. After resection, the liver was placed in a bag and perfused with a 
further 1–2 liters of UW solution. After implantation of the liver, the ex vivo 
perfusate was retrieved. Mononuclear cells from the perfusate were isolated 
within 12 h by density gradient centrifugation using Ficoll Paque Plus 
(GE Healthcare). PBMCs were obtained from organ donors. All samples were 
stored in 10% DMSO-containing medium at 180°C. The study protocol 
was approved by the Ethics Committee at King’s College Hospital.
Flow cytometry and FACS. Staining of cells for flow cytometry, intracel-
lular phospho-staining, and FACS was performed as previously described 
(Barone et al., 2011). Phospho-staining in PBMCs was performed after 
30 min of culture with heat-killed bacteria from human feces. Bacteria had 
been grown under aerobic and anaerobic conditions on blood-agar plates for 
48 h and were then washed and heat-killed for 10 min at 95°C. Flow cytometry 
and FACS were performed using the LSR II analyzer and FACS Aria (BD). 
Antibodies were used at concentrations recommended by the manufacturers: 
phospho-BTK, phospho-syk, phospho-ERK, CD79b, CD10, IgD, HLA-DR, 
and CD11c (all BD); CD19, CD38, CD27, CD24, and IgM (all BioLegend); 
CD20 efluor 450 and 7 (eBioscience); and dendritic cell exclusion (“lin-
eage”) cocktail (anti-CD3/CD14/CD16/CD19/CD34; AbD Serotec). The 
specificities of phospho-BTK, phospho-syk, and phospho-ERK were con-
firmed by the manufacturers by methods including Western blotting.
Immunofluorescence staining and immunohistochemistry. Cryosec-
tions were fixed with 4% paraformaldehyde, followed by antigen retrieval in 
citrate buffer, pH 9, for 10 min at 95°C. For immunofluorescence, sections 
were incubated with the primary Abs (CD10 and IgD; Dako) for 1 h, and then 
washed and incubated with Alexa-fluorochrome–conjugated secondary Abs 
(Invitrogen) and DAPI. Specific staining was confirmed using isotype control 
Abs. Confocal images were acquired with the LSM 510 Meta, Plan-Neofluar 
40× oil/0.50 objective (Carl Zeiss). Immunohistochemistry of paraffin sections 
was performed by UCL Advanced Diagnostics, London as previously described 
(Barone et al., 2009). CD20 was purchased from Dako and MAdCAM-1 from 
AbD Serotec.
RT-PCR. Quantitative PCR was done as described previously (Barone 
et al., 2009). Primers and probes to quantify retinoic acid receptor expres-
sion were purchased from Applied Biosystems and data standardized to 
GAPDH expression.
IGHV gene rearrangement analysis. IGHV gene rearrangements in DNA 
from sorted cells were PCR amplified with primers to each of the IgVH fami-
lies and a nested protocol used as described previously (Dunn-Walters et al., 
1995). PCR products were cloned into the pGEM-T vector (Promega) and 
sequenced by Beckman Coulter Sequencing Services (Beckman Coulter Ge-
nomics). Alignments were made using the IMGT/V-quest database.
B cell culture to assess autoantibody production. B cell subsets were 
sorted by FACS from Peyer’s patches or PBMCs from healthy individuals. 
Purified B cell subsets were cultured as previously described with minor al-
terations (Huggins et al., 2007). Cells were cultured at a density of 5 × 104 
cells/200-µl well in 96-well U-bottomed plates. The base cell culture media was 
IMDM (Invitrogen) with 10% human AB serum (Biosera), 50 µg/ml human 
transferrin, 5 µg/ml human insulin, 15 µg/ml gentamicin, and 100 U/ml 
penicillin-streptomycin. For the initial 5 d of culture, the base media was 
supplemented with 20 U/ml IL-2, 50 ng/ml IL-10, 10 ng/ml IL-15, and 
5 µl/well of heat-killed bacteria from human feces. After 5 d, supernatants 
were removed and replaced with base cell culture media supplemented 
with 20 U/ml IL-2, 50 ng/ml IL-6, 50 ng/ml IL-10, and 10 ng/ml IL-15. 
Cells were then transferred to 200-µl wells in U-bottomed plates lined 
with irradiated mouse fibroblasts (L-cells) expressing human CD40L. Super-
natants were collected after 3 d. Qualitative detection of autoantibodies 
suggested to share a common pool of cells from studies of 
infection and malignancy (Harris et al., 1996; Du et al., 1997). 
Recruitment to the marginal zone by activation in response 
to mucosal microbiota could provide the explanation for the 
responsiveness of this population to bacterial antigens and 
also their prior acquisition of mutations in IGHV. It would 
also explain the appearance of the splenic marginal zone that 
is responsive to bacterial antigens over the first 2 years of life 
and splenic marginal zone expansion after bacterial coloniza-
tion of the mucosa (Timens et al., 1989; Harris et al., 1996; 
Kruschinski et al., 2004).
The intestinal IgA-producing plasma cell population that 
is derived from B cells activated in GALT (Barone et al., 2011), 
while mostly antigen specific, includes a relatively high fre-
quency of cells secreting autoreactive and polyspecific anti-
bodies (Benckert et al., 2011; Scheid et al., 2011). This contrasts 
with the bone marrow IgG plasma cell population where auto-
reactivity is relatively rare. It is possible that recruitment of 
transitional B cells to GALT could enhance the antigen-binding 
spectrum of IgA antibody produced in the gut. IgA is trans-
ported into the intestinal lumen where antibody diversity is 
paramount but where autoreactivity is not a relevant issue. Con-
tinuous recruitment of T2 B cells could also contribute to the 
scale of IgA production that exceeds the production of all 
other isotypes in the body.
The lymphoid interface with the microbiome:  
a novel checkpoint in B cell development?
We propose that selective entry and activation of T2 cells in 
human GALT, as demonstrated here, would affect the devel-
oping B cell repertoire by removing a proportion of B cells 
from the circulating pool before differentiation to mature 
naive B cells. We therefore suggest that this could constitute a 
novel checkpoint. Failure to access GALT efficiently in SLE 
may contribute to disease pathogenesis. SLE is a complex 
condition with diverse manifestations. It is not yet clear how 
our data relate to each individual phenotype associated with 
this disease.
MATERIALS AND METHODS
Reagents. Reagents were purchased from Sigma-Aldrich if not stated oth-
erwise. CpG DNA was purchased from Thermo Fisher Scientific. The reti-
noic acid receptor (RAR) alpha antagonist Ro41 was purchased from Enzo 
Life Sciences.
Cell isolation and culture. Mononuclear cells from human peripheral 
blood and GALT were isolated as previously described (Vossenkämper et al., 
2010). An overview of the lupus patients is given in Table S1. Blood cells used 
as controls were obtained from healthy female individuals between the ages 
of 20 and 45. Peyer’s patch biopsies were obtained during routine endoscopy. 
All patients gave informed written consent. The study was preformed ac-
cording to human experimental guidelines and with approval of the NRES 
Committee London-City, and East and KCL infectious diseases BioBank, 
Local Research Ethics Committee working under the authority of the 
Southampton and South West Hampshire Research Ethics Committee. Cells 
were cultured in RPMI medium supplemented with 10% FBS, 100 U/ml 
penicillin, 100 µg/ml streptomycin, 2 mM l-Glutamine, and 1% nonessential 
amino acids.
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(i.e., immunoglobulin against Hep2 cell antigens) in cell supernatants was 
performed using the ANA-Hep2 Screen ELISA (IBL-America). To assess IgA 
content, the kit’s anti–IgG-enzyme conjugate was substituted with an anti–
IgA-peroxide conjugate (Sigma-Aldrich). Results (in optical densities) of the 
Hep2 ELISA were standardized to immunoglobulin concentrations in the 
supernatants (TIG ELISA kit; BlueGene) and were adjusted to eliminate any 
contribution from the human AB serum.
Aldefluor assay. Aldehyde dehydrogenase (ALDH) activity in blood DCs 
(identified as CD3/CD14/CD16/CD19/CD34, HLA-DR+, CD11c+ 
population) was assessed by using the Aldefluor reagent system (STEMCELL 
Technologies). Aldefluor is a fluorescent substrate for ALDH. Cells express-
ing high levels of ALDH appear brightly fluorescent and were identified dur-
ing flow cytometry by comparing the fluorescence in test samples to that in 
controls containing diethylaminobenzaldehyde (DEAB), a specific inhibitor 
of ALDH (Fig. S3).
Statistical analysis. Instat or Prism (GraphPad Software) was used to perform 
statistical tests. A two-tailed Student’s t test, Mann-Whitney-test, and 2 test 
were used as appropriate. The one-way ANOVA test was used to compare nor-
mally distributed multiple groups. Kruskal-Wallis was used for non-normally/
skewed distributed multiple groups. P < 0.05 was considered significant.
Online supplemental material. Fig. S1 shows full gating strategy for iden-
tifying transitional 1 (T1), transitional 2 (T2), and mature naive B cells based 
on their expression of CD19, CD20, CD27, CD24, and CD38. Fig. S2 shows 
FACS sort strategies for isolation of transitional, mature naive, and germinal 
center B cells from peripheral blood or Peyer’s patches. Fig. S3 shows a B cell 
7 expression after in vitro stimulation ALDH enzyme activity in blood myeloid 
DCs. Table S1 shows demographic and clinical details of the SLE and RA 
patients enrolled in this study. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20122465/DC1.
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